Annual Non Current Assets
$99.42 M
+$57.24 M+135.70%
December 31, 2023
Summary
- As of February 22, 2025, TRDA annual long term assets is $99.42 million, with the most recent change of +$57.24 million (+135.70%) on December 31, 2023.
- During the last 3 years, TRDA annual non current assets has risen by +$95.84 million (+2678.68%).
- TRDA annual non current assets is now at all-time high.
Performance
TRDA Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$89.25 M
-$3.17 M-3.43%
September 30, 2024
Summary
- As of February 22, 2025, TRDA quarterly long term assets is $89.25 million, with the most recent change of -$3.17 million (-3.43%) on September 30, 2024.
- Over the past year, TRDA quarterly non current assets has dropped by -$12.73 million (-12.49%).
- TRDA quarterly non current assets is now -14.00% below its all-time high of $103.79 million, reached on June 30, 2023.
Performance
TRDA Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
TRDA Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +135.7% | -12.5% |
| 3 y3 years | +2678.7% | +111.6% |
| 5 y5 years | +10000.0% | +111.6% |
TRDA Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1293.8% | -14.0% | +1151.3% |
| 5 y | 5-year | at high | >+9999.0% | -14.0% | +2394.6% |
| alltime | all time | at high | >+9999.0% | -14.0% | +2394.6% |
Entrada Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $89.25 M(-3.4%) |
| Jun 2024 | - | $92.43 M(-4.4%) |
| Mar 2024 | - | $96.67 M(-2.8%) |
| Dec 2023 | $369.77 M(+76.2%) | $99.42 M(-2.5%) |
| Sep 2023 | - | $101.99 M(-1.7%) |
| Jun 2023 | - | $103.79 M(+150.5%) |
| Mar 2023 | - | $41.43 M(-1.8%) |
| Dec 2022 | $209.88 M | $42.18 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $39.73 M(-5.4%) |
| Jun 2022 | - | $42.01 M(-4.5%) |
| Mar 2022 | - | $43.99 M(+516.7%) |
| Dec 2021 | $298.70 M(+647.7%) | $7.13 M(-19.6%) |
| Sep 2021 | - | $8.87 M(+50.9%) |
| Jun 2021 | - | $5.88 M(+64.3%) |
| Dec 2020 | $39.95 M(+129.1%) | $3.58 M |
| Dec 2019 | $17.44 M | - |
FAQ
- What is Entrada Therapeutics annual long term assets?
- What is the all time high annual non current assets for Entrada Therapeutics?
- What is Entrada Therapeutics annual non current assets year-on-year change?
- What is Entrada Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly non current assets year-on-year change?
What is Entrada Therapeutics annual long term assets?
The current annual non current assets of TRDA is $99.42 M
What is the all time high annual non current assets for Entrada Therapeutics?
Entrada Therapeutics all-time high annual long term assets is $99.42 M
What is Entrada Therapeutics annual non current assets year-on-year change?
Over the past year, TRDA annual long term assets has changed by +$57.24 M (+135.70%)
What is Entrada Therapeutics quarterly long term assets?
The current quarterly non current assets of TRDA is $89.25 M
What is the all time high quarterly non current assets for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly long term assets is $103.79 M
What is Entrada Therapeutics quarterly non current assets year-on-year change?
Over the past year, TRDA quarterly long term assets has changed by -$12.73 M (-12.49%)